The epidemiology of endometrial polyps is reported to be between 7.8 and 50% of women. The range remains quite broad and inconsistent due to confounding study factors such as the method of research, population studied, histological type and anatomical location of polyps. The development of polyps is influenced by a multitude of genetic and epigenetic factors. Chromosomes 6,7 and 12 are incriminated in this process. A fraction of these polyps may undergo malignant transformation, most commonly in postmenopausal patients. 3D ultrasound (US) and hysterosalpingo-contrast-sonography (HyCoSy) provide an accurate diagnosis and location of endometrial polyps (EPs). Expectant management is recommended when the polyp is up to 10mm in length, in asymptomatic young patients. When indicated, hysteroscopic removal of polyps can be performed as an outpatient without requiring a general anaesthetic. The use of a small tip diameter hysteroscope and 5Fr instruments offers safe, efficient and low-cost treatment. The hysteroscopic morcellator and shaver are the best surgical option for bigger polyps since it is a quick and time-effective method with the technique easily learned by surgeons.